Cargando…
Association Between Oregon’s 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed
IMPORTANCE: Eighteen states, including Oregon, have passed legislation requiring insurers to cover dispensation of a 12-month supply of short-acting, hormonal contraception. OBJECTIVE: To determine whether Oregon’s 2016 12-month supply law was associated with an increase in contraceptive supply rece...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903112/ https://www.ncbi.nlm.nih.gov/pubmed/35977278 http://dx.doi.org/10.1001/jamahealthforum.2021.5146 |
_version_ | 1784664700173156352 |
---|---|
author | Rodriguez, Maria I. Lin, Sunny C. Steenland, Maria McConnell, K. John |
author_facet | Rodriguez, Maria I. Lin, Sunny C. Steenland, Maria McConnell, K. John |
author_sort | Rodriguez, Maria I. |
collection | PubMed |
description | IMPORTANCE: Eighteen states, including Oregon, have passed legislation requiring insurers to cover dispensation of a 12-month supply of short-acting, hormonal contraception. OBJECTIVE: To determine whether Oregon’s 2016 12-month supply law was associated with an increase in contraceptive supply received. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study of hormonal contraceptive users using Oregon’s All Payer All Claims database examined the quantity of contraceptive supply dispensed 3 years before and 3 years after the 2016 policy change. We also assessed changes among patients attributed to Title X clinics. EXPOSURES: Legislation requiring insurers in Oregon to cover a 12-month supply of contraception to continuing users. MAIN OUTCOMES AND MEASURES: Receipt of a 12-month supply of hormonal contraception RESULTS: This cohort study of insured users (mean [SD] age, 27.4 [2.1] years) of short-acting hormonal contraception included 639 053 contraceptive prescriptions. Results indicated that more than 80% of prescriptions for contraceptives cover 3 months or fewer. Most women in the study population used the oral contraceptive pill, lived in a metropolitan area, and were privately insured. We did not observe a significant association between the passage of the 12-month supply policy and receipt of a 12-month supply (aOR, 1.01; 95% CI, 0.74-1.38). Receipt of a 12-month supply was more common for Medicaid recipients than the privately insured (aOR, 9.40; 95% CI, 6.62-13.34). We did find a shift from 1 month to 2 to 3 months supply being dispensed. The policy change was associated with a small, overall increase in quantity dispensed (0.27 months supply; 95% CI, 0.15 to –0.38). Title X clinics prescribed 3 months more of contraceptive supply than non–Title X clinics (3.03 months supply; 95% CI, 2.64-3.41). However, the policy change was not associated with increased contraceptive supply dispensed at Title X clinics. CONCLUSIONS AND RELEVANCE: In this cohort study of insured users of short-acting hormonal contraception, the passage of a 12-month contraceptive supply policy was not associated with an increase in contraceptive supply dispensed. |
format | Online Article Text |
id | pubmed-8903112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-89031122022-03-11 Association Between Oregon’s 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed Rodriguez, Maria I. Lin, Sunny C. Steenland, Maria McConnell, K. John JAMA Health Forum Original Investigation IMPORTANCE: Eighteen states, including Oregon, have passed legislation requiring insurers to cover dispensation of a 12-month supply of short-acting, hormonal contraception. OBJECTIVE: To determine whether Oregon’s 2016 12-month supply law was associated with an increase in contraceptive supply received. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study of hormonal contraceptive users using Oregon’s All Payer All Claims database examined the quantity of contraceptive supply dispensed 3 years before and 3 years after the 2016 policy change. We also assessed changes among patients attributed to Title X clinics. EXPOSURES: Legislation requiring insurers in Oregon to cover a 12-month supply of contraception to continuing users. MAIN OUTCOMES AND MEASURES: Receipt of a 12-month supply of hormonal contraception RESULTS: This cohort study of insured users (mean [SD] age, 27.4 [2.1] years) of short-acting hormonal contraception included 639 053 contraceptive prescriptions. Results indicated that more than 80% of prescriptions for contraceptives cover 3 months or fewer. Most women in the study population used the oral contraceptive pill, lived in a metropolitan area, and were privately insured. We did not observe a significant association between the passage of the 12-month supply policy and receipt of a 12-month supply (aOR, 1.01; 95% CI, 0.74-1.38). Receipt of a 12-month supply was more common for Medicaid recipients than the privately insured (aOR, 9.40; 95% CI, 6.62-13.34). We did find a shift from 1 month to 2 to 3 months supply being dispensed. The policy change was associated with a small, overall increase in quantity dispensed (0.27 months supply; 95% CI, 0.15 to –0.38). Title X clinics prescribed 3 months more of contraceptive supply than non–Title X clinics (3.03 months supply; 95% CI, 2.64-3.41). However, the policy change was not associated with increased contraceptive supply dispensed at Title X clinics. CONCLUSIONS AND RELEVANCE: In this cohort study of insured users of short-acting hormonal contraception, the passage of a 12-month contraceptive supply policy was not associated with an increase in contraceptive supply dispensed. American Medical Association 2022-02-18 /pmc/articles/PMC8903112/ /pubmed/35977278 http://dx.doi.org/10.1001/jamahealthforum.2021.5146 Text en Copyright 2022 Rodriguez MI et al. JAMA Health Forum. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Rodriguez, Maria I. Lin, Sunny C. Steenland, Maria McConnell, K. John Association Between Oregon’s 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed |
title | Association Between Oregon’s 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed |
title_full | Association Between Oregon’s 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed |
title_fullStr | Association Between Oregon’s 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed |
title_full_unstemmed | Association Between Oregon’s 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed |
title_short | Association Between Oregon’s 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed |
title_sort | association between oregon’s 12-month contraceptive supply policy and quantity of contraceptives dispensed |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903112/ https://www.ncbi.nlm.nih.gov/pubmed/35977278 http://dx.doi.org/10.1001/jamahealthforum.2021.5146 |
work_keys_str_mv | AT rodriguezmariai associationbetweenoregons12monthcontraceptivesupplypolicyandquantityofcontraceptivesdispensed AT linsunnyc associationbetweenoregons12monthcontraceptivesupplypolicyandquantityofcontraceptivesdispensed AT steenlandmaria associationbetweenoregons12monthcontraceptivesupplypolicyandquantityofcontraceptivesdispensed AT mcconnellkjohn associationbetweenoregons12monthcontraceptivesupplypolicyandquantityofcontraceptivesdispensed |